Literature DB >> 8346172

Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts.

G Monga1, G Mazzucco, B Basolo, S Quaranta, M Motta, G Segoloni, A Amoroso.   

Abstract

Twenty-two cases of membraneous glomerulonephritis (MGN) were identified among 256 bioptically investigated transplanted patients. MGN was defined as de novo in 15 patients and recurrent in three. The type of MGN could not be ascertained with certainty in the other four. Several morphologic features unusual for the idiopathic form of MGN were found. Most cases disclosed focal segmental distribution of subepithelial deposits and showed the contemporaneous presence of different stages of the disease according to Ehrenreich and Churg classification. In addition mild-to-moderate mesangial cell proliferation was found in about one third of de novo MGN biopsies. Endocapillary hypercellularity was observed in 14 specimens and held to be due to an excess of mononuclear blood cells, related to a concomitant episode of rejection. Chronic transplant glomerulopathy was found in 47% of patients with de novo MGN and in 66% of those with recurrent MGN, being more frequently observed in specimens with diffuse distribution of deposits. Repeated biopsies showed progression of the stage and extension of deposits to a large number of capillary loops in four out of six patients. De novo MGN was documented 1 to 54 mo (mean value 20.2 mo) after transplantation, and the recurrence was observed after 12, 15, and 42 mo. All but two patients (who were anuric) complained of proteinuria, which was in the nephrotic range in 12. Apart from the significantly higher frequency in de novo MGN patients of DR4 antigen, whose significance must in any case be re-evaluated in a larger series, none of the factors so far suggested to be linked to the onset of de novo MGN has found further support in our study. On the contrary, relevance in favoring the appearance and the evolution of MGN has to be attributed to transplant glomerulopathy, which, moreover, seems to be more important than MGN itself in causing the unfavorable outcome of the graft.

Entities:  

Mesh:

Year:  1993        PMID: 8346172

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  9 in total

1.  Membranous nephropathy caused by rheumatoid arthritis.

Authors:  Ayana Iida; Yukihiro Wada; Junichi Hayashi; Shohei Tachibana; Taro Inaba; Masayuki Iyoda; Kazuho Honda; Takanori Shibata
Journal:  CEN Case Rep       Date:  2019-04-29

2.  Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation.

Authors:  Ben Sprangers; George Ian Lefkowitz; Scott D Cohen; Michael Barry Stokes; Antony Valeri; Gerald B Appel; Cheryl L Kunis
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

3.  Anti-phospholipase A₂ receptor antibodies in recurrent membranous nephropathy.

Authors:  A Kattah; R Ayalon; L H Beck; S Sethi; D G Sandor; F G Cosio; M J Gandhi; E C Lorenz; D J Salant; F C Fervenza
Journal:  Am J Transplant       Date:  2015-03-12       Impact factor: 8.086

4.  Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.

Authors:  R Neal Smith; Fahim Malik; Nelson Goes; Alton B Farris; Emmanuel Zorn; Susan Saidman; Nina Tolkoff-Rubin; Sonika Puri; Waichi Wong
Journal:  Transpl Immunol       Date:  2012-08-30       Impact factor: 1.708

Review 5.  De novo glomerular diseases after renal transplantation.

Authors:  Claudio Ponticelli; Gabriella Moroni; Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 8.237

Review 6.  De novo glomerular diseases after renal transplantation: How is it different from recurrent glomerular diseases?

Authors:  Fedaey Abbas; Mohsen El Kossi; Jon Kim Jin; Ajay Sharma; Ahmed Halawa
Journal:  World J Transplant       Date:  2017-12-24

7.  The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation.

Authors:  Marc Xipell; Lida M Rodas; Jesús Villarreal; Alicia Molina; Johanna Reinoso-Moreno; Miquel Blasco; Esteban Poch; Fritz Diekmann; Jose M Campistol; Luis F Quintana
Journal:  Clin Kidney J       Date:  2017-11-22

Review 8.  Recurrent and de novo Glomerulonephritis After Kidney Transplantation.

Authors:  Wai H Lim; Meena Shingde; Germaine Wong
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

Review 9.  Recurrent Glomerulonephritis in the Kidney Allograft.

Authors:  Shane A Bobart; Mariam P Alexander; Andrew Bentall
Journal:  Indian J Nephrol       Date:  2020-11-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.